期刊
CA-A CANCER JOURNAL FOR CLINICIANS
卷 60, 期 6, 页码 351-375出版社
WILEY
DOI: 10.3322/caac.20082
关键词
-
类别
资金
- Morgan Welch Inflammatory Breast Cancer Research Program and Clinic
- State of Texas
- American Airlines Susan G. Komen for the Cure Promise [KGO81287]
Inflammatory breast cancer (IBC) is a rare and aggressive form of invasive breast cancer accounting for 2.5% of all breast cancer cases. It is characterized by rapid progression, local and distant metastases, younger age of onset, and lower overall survival compared with other breast cancers. Historically, IBC is a lethal disease with less than a 5% survival rate beyond 5 years when treated with surgery or radiation therapy. Because of its rarity, IBC is often misdiagnosed as mastitis or generalized dermatitis. This review examines IBC's unique clinical presentation, pathology, epidemiology, imaging, and biology and details current multidisciplinary management of the disease, which comprises systemic therapy, surgery, and radiation therapy. CA Cancer J Clin 2010;60:351-375. (C) 2010 American Cancer Society, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据